Merck & Co. Proceeds from (Repayments of) Short-Term Debt increased by 6973.3% to $1.06B in Q1 2026 compared to the prior quarter.
Frequent reliance on short-term debt may indicate working capital volatility, while consistent repayment suggests strong cash flow generation.
The net cash flow resulting from the issuance and repayment of short-term debt, such as commercial paper or revolving cr...
Standard metric for companies with seasonal or cyclical working capital requirements.
financing_proceeds_from_repayments_of_short_term_debt| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$4.77B | $0.00 | -$3.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $48.00M | $15.00M | $1.06B |
| QoQ Change | — | +100.0% | — | +100.0% | — | — | — | — | — | — | -68.8% | >999% |
| YoY Change | — | — | — | — | +100.0% | — | +100.0% | — | — | — | — | — |